PHARMA-TRADE A/S — Credit Rating and Financial Key Figures
Credit rating
Company information
About PHARMA-TRADE A/S
PHARMA-TRADE A/S (CVR number: 87339815K) is a company from GRIBSKOV. The company reported a net sales of 374.8 mDKK in 2023, demonstrating a growth of 11 % compared to the previous year. The operating profit percentage was at 11.9 % (EBIT: 44.7 mDKK), while net earnings were 34.4 mDKK. The profitability of the company measured by Return on Assets (ROA) was 13.8 %, which can be considered good and Return on Equity (ROE) was 14.3 %, which can be considered good. The equity ratio, a key indicator for solidity, stood at 73.9 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. PHARMA-TRADE A/S's liquidity measured by quick ratio was 3.7 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsNet sales (mDKK)
EBIT (mDKK)
Profitability
Solidity
Key figures (mDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | 323.04 | 334.73 | 366.15 | 337.74 | 374.75 |
Gross profit | 93.42 | 105.23 | 113.48 | 91.85 | 99.95 |
EBIT | 41.57 | 55.61 | 59.52 | 36.67 | 44.69 |
Net earnings | 30.17 | 41.08 | 46.44 | 28.01 | 34.35 |
Shareholders equity total | 214.97 | 233.22 | 242.44 | 238.09 | 242.44 |
Balance sheet total (assets) | 323.95 | 348.09 | 341.73 | 324.43 | 341.73 |
Net debt | -12.78 | -23.10 | -11.78 | 25.53 | -12.85 |
Profitability | |||||
EBIT-% | 12.9 % | 16.6 % | 16.3 % | 10.9 % | 11.9 % |
ROA | 13.0 % | 16.6 % | 17.3 % | 11.2 % | 13.8 % |
ROE | 14.3 % | 18.3 % | 19.5 % | 11.7 % | 14.3 % |
ROI | 14.3 % | 18.4 % | 19.1 % | 12.2 % | 15.2 % |
Economic value added (EVA) | 22.33 | 33.29 | 38.10 | 18.41 | 22.45 |
Solvency | |||||
Equity ratio | 66.4 % | 67.1 % | 71.0 % | 73.4 % | 73.9 % |
Gearing | 23.1 % | 19.9 % | 17.7 % | 16.7 % | 15.2 % |
Relative net indebtedness % | 10.3 % | 9.0 % | 8.0 % | 17.0 % | 5.7 % |
Liquidity | |||||
Quick ratio | 3.8 | 3.5 | 4.0 | 3.1 | 3.7 |
Current ratio | 6.0 | 5.4 | 6.6 | 6.2 | 6.6 |
Cash and cash equivalents | 62.49 | 69.47 | 54.79 | 14.16 | 49.76 |
Capital use efficiency | |||||
Trade debtors turnover (days) | 78.9 | 81.5 | 77.3 | 94.1 | 74.7 |
Net working capital % | 54.2 % | 54.8 % | 51.3 % | 51.5 % | 51.3 % |
Credit risk | |||||
Credit rating | AAA | AAA | AAA | AAA | AAA |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.